CIK 0001422142
- Non-accelerated filer
- Smaller reporting company
Whitehawk Therapeutics, Inc.
Sign in to watch- Ticker
- WHWK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 611547850
- Phone
- +1 551-321-2234
- Business address
- 2 HEADQUARTERS PLAZA, EAST BUILDING, 11TH FLOOR, MORRISTOWN, NJ, 07960
- Former names
- Aadi Bioscience, Inc., Aerpio Pharmaceuticals, Inc., ZETA ACQUISITION CORP II
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 9,689 shares at $1.94 ($18,797)
- 4 Open-market sale EXECUTIVE CHAIRMAN sold 40,000 shares at $1.71 ($68,316)
- 4 Open-market sale EXECUTIVE CHAIRMAN sold 40,000 shares at an average $1.43 ($57,354)
- 4 Open-market sale EXECUTIVE CHAIRMAN sold 40,000 shares at an average $1.43 ($57,217)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale EXECUTIVE CHAIRMAN sold 40,000 shares at an average $1.79 ($71,511)
- 4 Open-market sale EXECUTIVE CHAIRMAN sold 40,000 shares at $1.93 ($77,184)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale EXECUTIVE CHAIRMAN sold 40,000 shares at an average $2.27 ($90,614)
- 4 Open-market sale EXECUTIVE CHAIRMAN sold 42,000 shares at an average $2.02 ($84,641)
- 4 Derivatives Options or other derivatives
Page 4 of 14 · 263 filings